Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - perindopril arginine - film-coated tablet - 5 milligram(s) - ace inhibitors, plain; perindopril

Canada - English - Health Canada

pharmascience inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Canada - English - Health Canada

pharmascience inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - pravastatin sodium - tablets - 40 milligram - hmg coa reductase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - pravastatin sodium - tablets - 10 milligram - hmg coa reductase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - pravastatin sodium - tablets - 20 milligram - hmg coa reductase inhibitors

United Kingdom - English - myHealthbox

milpharm limited - pravastatin sodium - tablets - 10mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors

United Kingdom - English - myHealthbox

milpharm limited - pravastatin sodium - tablets - 20mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors

United Kingdom - English - myHealthbox

milpharm limited - pravastatin sodium - tablets - 40mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors

Canada - English - Health Canada

mylan pharmaceuticals ulc - ranitidine (ranitidine hydrochloride) - tablet - 75mg - ranitidine (ranitidine hydrochloride) 75mg - histamine h2-antagonists